220 related articles for article (PubMed ID: 24253538)
1. Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.
Modersitzki F; Pizzi L; Grasso M; Goldfarb DS
Urolithiasis; 2014 Feb; 42(1):53-60. PubMed ID: 24253538
[TBL] [Abstract][Full Text] [Related]
2. Cystine Stone Formers Have Impaired Health-Related Quality of Life Compared with Noncystine Stone Formers: A Case-Referent Study Piloting the Wisconsin Stone Quality of Life Questionnaire Among Patients with Cystine Stones.
Streeper NM; Wertheim ML; Nakada SY; Penniston KL
J Endourol; 2017 Apr; 31(S1):S48-S53. PubMed ID: 27717296
[TBL] [Abstract][Full Text] [Related]
3. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
Worcester EM; Coe FL; Evan AP; Parks JH
BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes for Cystinuria Patients with Unilateral Versus Bilateral Cystine Stone Disease.
Usawachintachit M; Sherer B; Hudnall M; Tzou DT; Taguchi K; Hsi RS; Stoller M; Chi T
J Endourol; 2018 Feb; 32(2):148-153. PubMed ID: 29179563
[TBL] [Abstract][Full Text] [Related]
5. Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy.
Modersitzki F; Goldfarb DS; Goldstein RL; Sur RL; Penniston KL
Urolithiasis; 2020 Aug; 48(4):313-320. PubMed ID: 31834425
[TBL] [Abstract][Full Text] [Related]
6. Staghorn cystine stone in a 72-year-old recurrent calcium stone former.
Cupisti A; Farnesi I; Armillotta N; Francesca F
Clin Nephrol; 2012 Jul; 78(1):76-80. PubMed ID: 22732341
[TBL] [Abstract][Full Text] [Related]
7. Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.
Labeeuw M; Gerbaulet C; Pozet N; Zech P; Traeger J
Urol Res; 1981; 9(4):163-8. PubMed ID: 7269003
[TBL] [Abstract][Full Text] [Related]
8. Disrupting Crystal Growth through Molecular Recognition: Designer Therapies for Kidney Stone Prevention.
Shtukenberg AG; Hu L; Sahota A; Kahr B; Ward MD
Acc Chem Res; 2022 Feb; 55(4):516-525. PubMed ID: 35088591
[TBL] [Abstract][Full Text] [Related]
9. Cystine stones: a single tertiary center experience.
Sfoungaristos S; Hakim R; Katz R; Gofrit ON; Landau EH; Yutkin V; Pode D; Duvdevani M
J Endourol; 2015 Mar; 29(3):362-6. PubMed ID: 25133928
[TBL] [Abstract][Full Text] [Related]
10. Conversion from Cystine to Noncystine Stones: Incidence and Associated Factors.
Reinstatler L; Stern K; Batter H; Scotland KB; Ardekani GS; Rivera M; Chew BH; Eisner B; Krambeck AE; Monga M; Pais VM
J Urol; 2018 Dec; 200(6):1285-1289. PubMed ID: 30059686
[TBL] [Abstract][Full Text] [Related]
11. Re: health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.
Assimos DG
J Urol; 2014 Jul; 192(1):142. PubMed ID: 25625159
[No Abstract] [Full Text] [Related]
12. Cystinuria: Review of a Life-long and Frustrating Disease.
Kowalczyk NS; Zisman AL
Yale J Biol Med; 2021 Dec; 94(4):681-686. PubMed ID: 34970106
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Bilateral Stone Disease on Patients' Disease Progression and Health-Related Quality of Life.
Raizenne BL; Deyirmendjian C; Lafontaine ML; Balde M; Bechis SK; Sur RL; Nakada SY; Antonelli JA; Streeper NM; Sivalingam S; Viprakasit DP; Averch TD; Landman J; Chi T; Pais VM; Chew BH; Bird VG; Andonian S; Canvasser NE; Harper JD; Penniston KL; Bhojani N
J Endourol; 2023 Dec; 37(12):1289-1294. PubMed ID: 37767631
[No Abstract] [Full Text] [Related]
14. Cystine crystal volume determination: a useful tool in the management of cystinuric patients.
Daudon M; Cohen-Solal F; Barbey F; Gagnadoux MF; Knebelmann B; Jungers P
Urol Res; 2003 Jul; 31(3):207-11. PubMed ID: 12748836
[TBL] [Abstract][Full Text] [Related]
15. Cystine stones: the efficacy of percutaneous and shock wave lithotripsy.
Cranidis AI; Karayannis AA; Delakas DS; Livadas CE; Anezinis PE
Urol Int; 1996; 56(3):180-3. PubMed ID: 8860740
[TBL] [Abstract][Full Text] [Related]
16. The impact of cystinuria on renal function.
Assimos DG; Leslie SW; Ng C; Streem SB; Hart LJ
J Urol; 2002 Jul; 168(1):27-30. PubMed ID: 12050485
[TBL] [Abstract][Full Text] [Related]
17. Stone formation in patients less than 20 years of age is associated with higher rates of stone recurrence: Results from the Registry for Stones of the Kidney and Ureter (ReSKU).
Li Y; Bayne D; Wiener S; Ahn J; Stoller M; Chi T
J Pediatr Urol; 2020 Jun; 16(3):373.e1-373.e6. PubMed ID: 32280060
[TBL] [Abstract][Full Text] [Related]
18. Radiopacity and hounsfield attenuation of cystine urolithiasis: case series and review of the literature.
Patel SR; Wagner LE; Lubner MG; Nakada SY
J Endourol; 2014 Apr; 28(4):472-5. PubMed ID: 24228639
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Evidence of Decreased Disease-Specific Health-Related Quality of Life in Asymptomatic Stone Patients.
Penniston KL; Sninsky BC; Nakada SY
J Endourol; 2016 May; 30 Suppl 1():S42-5. PubMed ID: 26864746
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
